AstraZeneca is a leader in cancer treatments with FDA-approved drugs. Read why AZN stock is still a 'Buy' and why the company’s future looks bright.

Shares of AstraZeneca PLC AZN inched up 0.05% to £110.46 Thursday, on what proved to be an all-around positive trading ...

AstraZeneca will invest 820 million Canadian dollars, equivalent to $570.3 million, to facilitate a move to a larger office in the Toronto metro area. The Anglo-Swedish pharmaceutical giant said ...

AstraZeneca is expanding its boot print in Canada with a $570 million investment designed to create 700 jobs. | AstraZeneca is expanding its boot print in Canada with a $570 million investment ...

For people with atrial fibrillation (Afib), investigational abelacimab proved to be a potent dual factor XI/XIa inhibitor with much lower safety risks compared with a direct oral anticoagulant (DOAC), ...

U.K. pharmaceutical company says Canadian presence will contribute to its goal of bringing 20 new medicines to market by 2030 ...

NDAQ:AZN) AstraZeneca plans C$820 million (US$570m) investment in Canada to advance growing global hub and clinical delivery ...

New jobs are coming to a Mississauga company. Officials gathered at the Mississauga-based biopharmaceutical company AstraZeneca Canada on Thursday to announce $16.1 million in funding through the ...

NEW YORK, NY / ACCESS Newswire / January 22, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn ...

Monopar Therapeutics Inc . (NASDAQ:MNPR) stock soared to a 52-week high, reaching a price level of $38.91. According to ...

Indian prime minister Narendra Modi had plans for India become a $5 trillion economy by 2025. The country is still over $1 ...

The addition of anthracyclines to adjuvant taxane-based chemotherapy improved survival for certain high-risk patients with ...